|
Market Closed -
London S.E.
18:35:09 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,779.50 GBX | -0.86% |
|
-5.19% | -2.47% |
| 12:52pm | Major drugmakers turn to China for licensing deals | RE |
| 10-01 | GSK plc : JP Morgan reiterates its Sell rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 95.02B | |||||
| 1,025B | |||||
| 623B | - | ||||
| 459B | |||||
| 355B | |||||
| 336B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
